Matches in Wikidata for { <http://www.wikidata.org/entity/Q37675239> ?p ?o ?g. }
- Q37675239 description "article científic" @default.
- Q37675239 description "article scientifique" @default.
- Q37675239 description "articolo scientifico" @default.
- Q37675239 description "artigo científico" @default.
- Q37675239 description "artículu científicu espublizáu en 2017" @default.
- Q37675239 description "bilimsel makale" @default.
- Q37675239 description "scientific article published on 06 January 2017" @default.
- Q37675239 description "vedecký článok" @default.
- Q37675239 description "vetenskaplig artikel" @default.
- Q37675239 description "videnskabelig artikel" @default.
- Q37675239 description "vědecký článek" @default.
- Q37675239 description "wetenschappelijk artikel" @default.
- Q37675239 description "wissenschaftlicher Artikel" @default.
- Q37675239 description "наукова стаття, опублікована в січні 2017" @default.
- Q37675239 description "научни чланак" @default.
- Q37675239 description "مقالة علمية نشرت في 06 يناير 2017" @default.
- Q37675239 name "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 name "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 name "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes." @default.
- Q37675239 type Item @default.
- Q37675239 label "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 label "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 label "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes." @default.
- Q37675239 prefLabel "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 prefLabel "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 prefLabel "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes." @default.
- Q37675239 P1104 Q37675239-DBB16A5A-C9C8-4B27-AF79-6151627B9AAA @default.
- Q37675239 P1433 Q37675239-1E97CF61-4C5A-46F1-81C1-08EDF28038C9 @default.
- Q37675239 P1476 Q37675239-3E97B0F5-B8F3-4C54-9D66-210C422C9958 @default.
- Q37675239 P2093 Q37675239-02136288-0CC2-4A2B-B1F5-C373007F138B @default.
- Q37675239 P2093 Q37675239-34BF2806-7F80-4668-815A-ABCBCC4B0E9B @default.
- Q37675239 P2093 Q37675239-56C0668B-B269-4F9C-B800-2B53A21E35FF @default.
- Q37675239 P2093 Q37675239-607096E7-7EA1-4AD7-82BC-AA8257BEBE03 @default.
- Q37675239 P2093 Q37675239-8E4E69FF-C2CD-4674-AB57-03D55521ADA7 @default.
- Q37675239 P2093 Q37675239-D2CB11CE-9F3B-475B-AEB2-F45C8952D24F @default.
- Q37675239 P2093 Q37675239-E7F38479-C706-4FCC-9E43-BF9396275568 @default.
- Q37675239 P275 Q37675239-b98f5abd-c1e9-4a5d-8f80-d7c0e045b692 @default.
- Q37675239 P2860 Q37675239-194F5C98-B3C6-4CB3-9BF1-85E2C4D5D62C @default.
- Q37675239 P2860 Q37675239-19A31C38-9A14-4115-8414-CE9BD49828E3 @default.
- Q37675239 P2860 Q37675239-19F2D449-35BE-43E8-B820-EE2FDB5B1D86 @default.
- Q37675239 P2860 Q37675239-350407FC-F241-4F01-B205-D59A993B9480 @default.
- Q37675239 P2860 Q37675239-44BFF066-72FC-44DB-9FA0-73AF0CCE22EC @default.
- Q37675239 P2860 Q37675239-7FBF964F-BC8A-454D-BC1B-D08A615A575B @default.
- Q37675239 P2860 Q37675239-80BDCA2C-B57C-439C-AD26-F076A2D414B8 @default.
- Q37675239 P2860 Q37675239-938DE7EF-2E84-4A28-8204-89286CAD5249 @default.
- Q37675239 P2860 Q37675239-94B06C2B-E953-400D-8D2E-A633D0690D5C @default.
- Q37675239 P2860 Q37675239-A316F320-3F3B-43AC-BC57-3D966958E70F @default.
- Q37675239 P2860 Q37675239-A80384F8-5506-4CBC-A3BE-5ED07A4CC077 @default.
- Q37675239 P2860 Q37675239-B637CCD1-E3B6-4A38-8E07-ACFAE27A14C1 @default.
- Q37675239 P2860 Q37675239-B6870D91-DB40-4A71-A98A-B63EF6D87182 @default.
- Q37675239 P2860 Q37675239-B8E21253-2799-49BF-9714-B51C84388795 @default.
- Q37675239 P2860 Q37675239-BF887D36-C9F4-4CD6-8766-283D9DD21E3C @default.
- Q37675239 P2860 Q37675239-DD5D60D4-F2B6-4FE1-884E-6EB25B50394E @default.
- Q37675239 P2860 Q37675239-E473C88D-52CE-4628-AF3A-F1528B9C9B14 @default.
- Q37675239 P2860 Q37675239-F232CD8B-36DD-4CE7-B922-868649374416 @default.
- Q37675239 P2888 Q37675239-7FC0FA4E-F51C-4DDC-ABF4-1FCF39802238 @default.
- Q37675239 P304 Q37675239-BD6C3F64-58B4-49F7-874D-0C0BF54A066C @default.
- Q37675239 P31 Q37675239-719BB49B-C2F3-4214-A51E-62CF66949AB7 @default.
- Q37675239 P356 Q37675239-7C6630A3-ECD3-4D2B-BEA8-0268D58566C2 @default.
- Q37675239 P433 Q37675239-219B6BD8-51C0-4BCD-8296-A5480824BE8B @default.
- Q37675239 P478 Q37675239-4D81D4A6-E98B-4DE5-9CAD-F4E2ED9DAC3B @default.
- Q37675239 P577 Q37675239-17E51F7B-0D89-4041-A156-E896E2A88627 @default.
- Q37675239 P6216 Q37675239-5b46f90b-9ea6-45cd-8339-16fda97a005c @default.
- Q37675239 P698 Q37675239-C23E4097-BEC7-4F53-AFB9-4A1661813723 @default.
- Q37675239 P921 Q37675239-39190409-479f-65aa-57fb-ecb9fe05f37b @default.
- Q37675239 P921 Q37675239-F902BFC6-A99B-4490-9A92-4F3033019901 @default.
- Q37675239 P932 Q37675239-BD41F7A6-F81E-4466-87B9-510D3009CE8D @default.
- Q37675239 P356 S40801-016-0102-5 @default.
- Q37675239 P698 28063028 @default.
- Q37675239 P1104 "+7" @default.
- Q37675239 P1433 Q27726504 @default.
- Q37675239 P1476 "HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes" @default.
- Q37675239 P2093 "Bongin Yoo" @default.
- Q37675239 P2093 "Debra Patt" @default.
- Q37675239 P2093 "Hans-Peter Goertz" @default.
- Q37675239 P2093 "Nicholas J Robert" @default.
- Q37675239 P2093 "Pooja Chopra" @default.
- Q37675239 P2093 "Vincent Antao" @default.
- Q37675239 P2093 "Xiaolong Jiao" @default.
- Q37675239 P275 Q34179348 @default.
- Q37675239 P2860 Q24305421 @default.
- Q37675239 P2860 Q27851691 @default.
- Q37675239 P2860 Q27853134 @default.
- Q37675239 P2860 Q29547383 @default.
- Q37675239 P2860 Q33827808 @default.
- Q37675239 P2860 Q36714370 @default.
- Q37675239 P2860 Q37433324 @default.
- Q37675239 P2860 Q37523202 @default.
- Q37675239 P2860 Q38036549 @default.
- Q37675239 P2860 Q38132047 @default.
- Q37675239 P2860 Q38132527 @default.
- Q37675239 P2860 Q38209628 @default.
- Q37675239 P2860 Q40700178 @default.
- Q37675239 P2860 Q41020913 @default.
- Q37675239 P2860 Q41087264 @default.
- Q37675239 P2860 Q44120544 @default.
- Q37675239 P2860 Q44120928 @default.
- Q37675239 P2860 Q51925963 @default.
- Q37675239 P2888 s40801-016-0102-5 @default.
- Q37675239 P304 "1-7" @default.